Table 22:

Scenario 5: Extending Coverage to Young Adults (OHIP+ Scenario)

	Year 1	Year 2	Year 3	Year 4	Year 5
No. of people in Ontario aged 15 to 24 ya No. of people aged 15 to 24 y with major depressionb No. of people aged 15 to 24 eligible for multi-gene pharmacogenomic testingc	1,798,491 86,328 25,898	1,823,917 87,548 26,264	1,847,143 88,663 26,599	1,867,725 89,651 26,895	1,879,433 90,213 27,064
No. of people in Ontario aged ≥ 25 ya No. of people with major depression aged ≥ 25 yb No. of people eligible for multi-gene pharmacogenomic testing aged ≥ 25 yc	10,785,699 517,714 155,314	10,962,097 526,181 157,854	11,126,282 534,062 160,218	11,282,015 541,537 162,461	11,431,084 548,692 164,608

^aProjection based on data from Ontario Ministry of Finance.

^bAssuming major depression prevalence of 4.8%.⁴

^cAssuming that 30% of people with major depression are eligible for testing as in the reference case.⁸